Novo Nordisk
Chamila Deshani Ranawakage is an accomplished Advanced Equipment and Method Validation Engineer currently at Novo Nordisk. Previously, Chamila served as a Scientist in QC Biochemistry at Bavarian Nordic, where notable achievements included GMP equipment qualification, analytical method validation, and authorship of standard operating procedures. Additional experience includes a postdoctoral role at the University of Minnesota Medical School focusing on stem cell research and RNA-seq analysis, as well as clinical research coordination at the National Cancer Institute in Sri Lanka. Chamila's academic background includes a PhD in Molecular Developmental Biology from Kochi University of Technology, an MSc in Immune Regulation from Tokushima University, and a BSc in Biochemistry and Molecular Biology from the University of Colombo.
This person is not in any teams
Novo Nordisk
375 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.